NRX Pharmaceuticals, Inc. (NRXP)
3.43
-0.24
(-6.54%)
USD |
NASDAQ |
Aug 26, 13:48
NRX Pharmaceuticals Total Liabilities (Quarterly) : 34.33M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.33M |
| March 31, 2026 | 25.72M |
| December 31, 2025 | 28.89M |
| September 30, 2025 | 40.75M |
| June 30, 2025 | 40.45M |
| March 31, 2025 | 32.75M |
| December 31, 2024 | 26.87M |
| September 30, 2024 | 23.28M |
| June 30, 2024 | 23.66M |
| March 31, 2024 | 18.86M |
| December 31, 2023 | 19.05M |
| September 30, 2023 | 19.33M |
| June 30, 2023 | 22.62M |
| March 31, 2023 | 22.06M |
| December 31, 2022 | 18.41M |
| September 30, 2022 | 8.042M |
| June 30, 2022 | 7.081M |
| March 31, 2022 | 11.91M |
| Date | Value |
|---|---|
| December 31, 2021 | 11.92M |
| September 30, 2021 | 36.77M |
| June 30, 2021 | 58.31M |
| March 31, 2021 | 4.808M |
| December 31, 2020 | 46.71M |
| September 30, 2020 | 2.831M |
| June 30, 2020 | 2.651M |
| March 31, 2020 | 2.497M |
| December 31, 2019 | 2.574M |
| September 30, 2019 | 2.434M |
| June 30, 2019 | 2.108M |
| March 31, 2019 | 1.981M |
| December 31, 2018 | 1.257M |
| September 30, 2018 | 0.3756M |
| June 30, 2018 | 0.2174M |
| March 31, 2018 | 0.0651M |
| December 31, 2017 | 0.0932M |
| September 30, 2017 | 0.15M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 108.40B |
| Pfizer Inc. | 115.64B |
| Oramed Pharmaceuticals, Inc. | 52.17M |
| Yarrow Bioscience, Inc. | 1.542M |
| ANI Pharmaceuticals, Inc. | 896.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.16M |
| Shareholders Equity (Quarterly) | -0.17M |
| Debt to Equity Ratio | -7.329 |
| Current Ratio | 0.8608 |
| Net Debt Paydown Yield | 0.81% |